Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08JCU
|
||||
| Former ID |
DNC007934
|
||||
| Drug Name |
(E)-2-(4-fluorostyryl)-5-(phenylsulfinyl)pyridine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528690] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H14FNOS
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)S(=O)C2=CN=C(C=C2)C=CC3=CC=C(C=C3)F
|
||||
| InChI |
1S/C19H14FNOS/c20-16-9-6-15(7-10-16)8-11-17-12-13-19(14-21-17)23(22)18-4-2-1-3-5-18/h1-14H/b11-8+
|
||||
| InChIKey |
YFWOOEBYKGJCJO-DHZHZOJOSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [528690] | |
| 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [528690] | ||
| 5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [528690] | ||
| PathWhiz Pathway | Muscle/Heart Contraction | ||||
| WikiPathways | SIDS Susceptibility Pathways | ||||
| Hematopoietic Stem Cell Differentiation | |||||
| Potassium ChannelsWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
| Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| Monoamine GPCRs | |||||
| GPCRs, Class A Rhodopsin-like | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.